Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2- advanced breast cancer in Europe
欧洲HR+/HER2-晚期乳腺癌患者一线接受帕博西尼联合芳香化酶抑制剂治疗的真实世界临床结果
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-025-07707-5
Oikonomidou, Olga; Beresford, Mark J; Galve-Calvo, Elena; Woeckel, Achim; Parikh, Rohan C; Hitchens, Abigail; Chen, Connie; Doan, Justin; Li, Benjamin; Ansquer, Valerie Derrien; Frugier, Gaelle; Jimenez, Maria I; Davis, Keith L; Broughton, Edward I